For the Inventor, By the Inventor

Enter assignee name

Glytech, Inc.

USPTO Granted Patents = 38

% Expired Patents = 15.8

CIPO Patents = 5

EPO Patents = 30

Forward Citations = 75

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Yasuhiro Kajihara (12 out of 25 patents)

Daniel C Javitt (9 out of 19 patents)

Kazuhiro Fukae (9 out of 17 patents)

4. Hirofumi Ochiai (7 out of 7 patents)

5. Izumi Sakamoto (7 out of 8 patents)

6. Masatoshi Maeda (6 out of 13 patents)

7. Keisuke Tazuru (6 out of 6 patents)

8. Kenta Yoshida (6 out of 6 patents)

9. Taiji Shimoda (6 out of 6 patents)

10. Kazuyuki Ishii (6 out of 11 patents)

11. Katsunari Tezuka (6 out of 26 patents)

12. Takefumi Murase (5 out of 5 patents)

13. Ryo Okamoto (4 out of 4 patents)

14. Takashi Tsuji (3 out of 52 patents)

15. Hiroaki Asai (3 out of 7 patents)

Core Competencies:

Artificial Protein Catalyst

Peptide Thioester

Post-Traumatic Stress Disorder

Amino-Acid Polymer

Glycosylated Polypeptide

Sialylated Sugar Chains

Glycopeptide

Chondroitin Synthase

Sugar Chain Derivative

D-Serine Transport Antagonist

Glycine Substitutes

Therapeutic Formulations

38 patents: Sort by Forward Citations

1. 12269021 - Artificial protein catalyst (2025-04-08),

2. 12103947 - Methods for producing peptide thioester and peptide (2024-10-01),

3. 11969431 - Formulations for treatment of post-traumatic stress disorder (2024-04-30),

4. 11576911 - Composition and method for treatment of depression and psychosis in humans (2023-02-14),

5. 11214592 - Production method for amino-acid polymer (2022-01-04),

6. 10913763 - Method for producing sugar having sulfate group and/or phosphate group (2021-02-09),

7. 10881665 - Formulations for treatment of post-traumatic stress disorder (2021-01-05),

8. 10683341 - Albumin-sugar chain complex (2020-06-16),

9. 10660887 - Composition and method for treatment of depression and psychosis in humans (2020-05-26),

10. 10583138 - Composition and method for treatment of depression and psychosis in humans (2020-03-10),

11. 10358470 - Glycosylated polypeptide and pharmaceutical composition containing same (2019-07-23),

12. 10202469 - Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same (2019-02-12),

13. 10053499 - Polypeptide having sialylated sugar chains attached thereto (2018-08-21),

14. 10047042 - Method for producing D-form or L-form amino acid derivative having thiol group (2018-08-14),

15. 9981059 - Sugar chain-polypeptide complex (2018-05-29),

Company Overview

Glytech, Inc. is a Japanese company based in Kyoto, specializing in the development and manufacturing of advanced materials and technologies for various applications. The organization focuses on innovative solutions in the fields of biotechnology and pharmaceuticals, particularly in the synthesis and application of glycoscience. Glytech's research efforts aim to enhance the efficacy and safety of therapeutic agents, contributing to advancements in healthcare and medical research on a global scale.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

38 Patents

#71 in Kyoto 615-0031

#2,025 in Japan

#17,831 in the World

Glytech, Inc.

Forward Citations = 75

49 inventors:

Yasuhiro Kajihara (12 out of 25 patents)

Daniel C Javitt (9 out of 19 patents)

Kazuhiro Fukae (9 out of 17 patents)

4. Hirofumi Ochiai (7 out of 7 patents)

5. Izumi Sakamoto (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glytech, Inc.. Retrieved from https://idiyas.com/company/glytech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…